Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_assertion type Assertion NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_head.
- NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_assertion description "[The authors' studies demonstrate that TRP-2 could be a useful antigen target for monitoring or developing immunotherapeutic strategies for glioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_provenance.
- NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_assertion evidence source_evidence_literature NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_provenance.
- NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_assertion SIO_000772 12843792 NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_provenance.
- NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_assertion wasDerivedFrom befree-20140225 NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_provenance.
- NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_assertion wasGeneratedBy ECO_0000203 NP651856.RAzmqQMNEAUNZU8eRE9Rp02GwgVd8IXm6TH81ztxZQCjI130_provenance.